IRIS
MUSOLINO, Caterina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.717
EU - Europa 4.744
AS - Asia 962
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 4
AF - Africa 2
Totale 11.443
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.691
IE - Irlanda 1.503
SE - Svezia 1.234
CN - Cina 728
IT - Italia 626
UA - Ucraina 356
DE - Germania 280
FI - Finlandia 211
PL - Polonia 179
GB - Regno Unito 142
SG - Singapore 118
FR - Francia 61
IN - India 56
BE - Belgio 52
AT - Austria 32
VN - Vietnam 27
CA - Canada 21
NL - Olanda 17
CZ - Repubblica Ceca 11
IR - Iran 11
RU - Federazione Russa 11
AU - Australia 6
ES - Italia 6
KR - Corea 6
CH - Svizzera 5
MX - Messico 5
RO - Romania 5
TW - Taiwan 5
DK - Danimarca 4
EU - Europa 4
IL - Israele 4
NZ - Nuova Zelanda 4
NO - Norvegia 3
TR - Turchia 3
BR - Brasile 2
CO - Colombia 2
GR - Grecia 2
ID - Indonesia 2
BG - Bulgaria 1
EG - Egitto 1
GH - Ghana 1
IQ - Iraq 1
JP - Giappone 1
LT - Lituania 1
LV - Lettonia 1
PT - Portogallo 1
Totale 11.443
Salva come PNG Salva come JPEG
Città #
Dublin 1.503
Chandler 1.266
Jacksonville 800
Nyköping 723
Beijing 320
Messina 311
Ashburn 280
Princeton 279
Dearborn 268
Medford 258
Des Moines 212
Cambridge 209
Ann Arbor 185
Warsaw 174
Boardman 140
New York 79
Woodbridge 77
Singapore 63
Wilmington 62
San Mateo 56
Brussels 52
Jinan 50
Shenyang 41
Nanjing 38
Hebei 36
Lancaster 36
Tianjin 34
Pune 33
Bremen 32
Vienna 32
Seattle 28
Dong Ket 27
Hangzhou 25
Houston 24
Strasbourg 23
Zhengzhou 22
Ningbo 20
Haikou 18
Helsinki 16
Rome 16
Norwalk 15
Auburn Hills 14
Falls Church 14
Palermo 14
Washington 14
Milan 12
Lanzhou 11
Los Angeles 11
Augusta 10
Guangzhou 10
Hyderabad 10
Jiaxing 10
Ottawa 10
Taizhou 10
Catania 9
Fuzhou 9
Nanchang 9
Changsha 8
Monmouth Junction 8
Taiyuan 8
Ardabil 7
Brno 7
Leawood 6
Munich 6
Amsterdam 5
Capoterra 5
Latina 5
Piazza Armerina 5
Redwood City 5
Cosenza 4
Ferrandina 4
Francofonte 4
Hefei 4
Modica 4
Petrosino 4
Turin 4
Xi'an 4
Acireale 3
Brindisi 3
Chapel Hill 3
Esher 3
Fremont 3
Gangdong-gu 3
Kelowna 3
Kunming 3
Lausanne 3
Madrid 3
Mumbai 3
Redmond 3
Saint Petersburg 3
Tappahannock 3
Arlington 2
Auckland 2
Avola 2
Barcelona 2
Berlin 2
Cajica 2
Civitanova Marche 2
Cordenons 2
Crosia 2
Totale 8.227
Salva come PNG Salva come JPEG
Nome #
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy 105
Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura 102
Raman spectroscopy differentiates between sensitive and resistant multiple myeloma cell lines 95
Low-energy laser irradiation promotes cellular damage in glucocorticoid-resistant multiple myeloma cells. 94
Phage-AgNPs complex as SERS probe for U937 cell identification 92
The cancer stem cell hypothesis: a guide to potential molecular targets. 90
Comportamento di alcuni indici della fibrinolisi in dislipidemici in corso di trattamento con sinfibrato" 87
Corneal Structural Changes in Nonneoplastic and Neoplastic Monoclonal Gammopathies 86
Role of the microbiota in hematologic malignancies. 84
L'ipersplenismo: attualità e prospettive future 83
Cutaneous adverse reactions to lenalidomide. 82
Absence of the V617F JAK2 Mutation in the Lymphoid Compartment in a Patient with Essential Thrombocythemia and B-Chronic Lymphocytic Leukemia and in Two Relatives with Lymphoproliferative Disorders 79
Altered Microrna Expression Profile in the peripheral Lymphomonocytes of Multiple Myeloma Patients with Bisphosphonate-Induced Osteonecrosis of the Jaw 79
Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1. 77
Disappearance of Acquired Hemophilia A after Complete Remission in a Multiple Myeloma Patient. 76
Challenge test to bisphosphonates in patients with hypersensitivity reactions to drugs. 75
SIRT1 and SIRT2 Expression correlates with advanced disease and bone lesions in Multiple Myeloma 75
Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw 75
E rosette formation in B cell chronic lymphocytic leukemia. 73
Extramedullary plasmacytoma of the maxilla simulating a maxillary radicular cyst: Quick diagnosis and management 73
Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies 73
Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors 71
Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer. 71
Bisphosphonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws 71
MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndrome 70
ASSETTO EMATOLOGICO DI UN GRUPPO DI SOGGETTIAFFETTI DA MORBO DI COOLEY:STUDIO DEL COMPORTAMENTO DELL'ERITROPOIETINA PLASMATICA 68
Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma 68
Efficacia della chemioterapia convenzionale ad alte dosi in un caso di mieloma multiplo IgM primitivamente doppio-refrattario ai nuovi farmaci 67
Telomerase and telomere biology in hematological diseases: A new therapeutic target 66
Circulating levels of intercellular adhesion Molecule-1 (ICAM-1) and soluble Interleukin 2 receptors(IL-2R) in patients with B cell Chronic Lynphocityc Leukemia 65
How gene polymorphisms can influence clinical response and toxicity following R-CHOP therapy in patients with diffuse large B cell lymphoma 65
ARA-C a basse dosi nelle sindrome mielodisplastiche in differenti stati evolutivi 64
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma. 64
Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-kB pathways 64
Evaluation of Interleukin-17 serum levels in patients with chronic myeloproliferative diseases. 63
Aggregazione piastrinica in dislipidemici in corso di trattamento con simfibrato 63
Angiogenesis in patients with biphosphonate-associated osteonecrosis of the jaw 62
Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and n two relatives with lymphoproliferative disorders 62
A rare spinal localization of gray zone lymphoma without mediastinal involvement: A case report and review of literature 62
Assenza della mutazione JAK2 V617F nel compartimento linfoide di un paziente affetto da trombocitemia essenziale e leucemia linfatica cronica a cellule B ed in due parenti affetti da disordini linfoproliferativi 61
A micro-Raman spectroscopic investigation of leukemic U-937 cells in aged cultures 61
Serum levels of soluble ICAM-1 in patients with malignant lymphoma in association with treatment response. 60
Serum levels of interleukin-16 in lymphoid malignancies. 60
Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cells 60
Immunohistochemical evaluation of sarcoglycans and integrin in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw 59
Immunohistochemical evaluation of sarcoglycans and integrins in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw. 59
Increased levels of the soluble adhesion molecule E-selectin in patients with chronic myeloproliferative disorders and thromboembolic complications 59
Beta 2 microglobulina ed emopatie maligne 58
Antiresorptive Agents and Anti-Angiogenesis Drugs in the Development of Osteonecrosis of the Jaw. 58
ABERRANT EXPRESSION OF CANCER TESTIS ANTIGENS IN HEMATOLOGIC MALIGNANCIES 57
Amyloid myopathy presenting with rhabdomyolysis: Evidence of complement activation 57
Evaluation of circulating endothelial cells, VEGF and VEGFR2 serum levels in patients with chronic myeloproliferative diseases. 57
Vaccination of multiple myeloma: Current strategies and future prospects 57
EVALUATION OF DECORIN AND BIGLYCAN GENE EXPRESSION IN LYMPHOCYTES FROM PATIENTS WITH CHRONIC LYMPHATIC LEUKAEMIA. 56
Elevated srum concentration of angiopoietin-2 in patients with multiple myeloma: correlation with markers of disease 56
Circulating levels of intercellular adhesion molecule-1 (ICAM-1) and soluble interleukin 2 receptors (IL-2R) in patients with B cell chronic lymphocytic leukaemia. 56
Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma 56
Evaluation of hepatitis B and C virus infections in patients with non-Hodgkin's lymphoma and without liver disease 55
Carbonyl groups serum levels are associated with CD38 expression in patients with B chronic lymphocytic leucemia. 55
Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review). 54
Lipid profile in hematologic neoplasms 53
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 53
A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients 53
Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501 and HLA-DQB1*0602. 53
SOLUBLE ANGIOGENIC FACTORS: IMPLICATIONS FOR CHRONIC MYELOPROLIFERATIVE DISORDERS 52
Evaluation des sous-populations lymphocytaires chez des travailleurs exposés a basse dose du benzene. Données préliminaires”. 52
Vaccination strategies in lymphoproliferative disorders: Failures and successes 52
Avascular Necrosis of Bone in Leukemia and Osteonecrosis of Jaw by Bisphosphonates 52
Circulating endothelial progenitor cells and angiogenic serum factors in patients with chronic myeloproliferative diseases 51
MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis. 51
Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension 51
Hepatitis B Virus Causes Epigenetic Induction of Interleukin-8Production which in Turn Inhibits Interferon-alfa Antiviral Activity 51
Recombinant human granulocyte colony-stimulating factor reverts vascular dysfunction 50
MARKERS OF ENDOTHELIAL AND PLATELET STATUS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND PLYCYTHEMIA VERA 50
Purpuric gloves and socks syndrome caused by parvovirus B19 infection 50
Cardiac involvement in patients with hematologic malignancies. 50
Efficacia di Nilotinib in un giovane paziente affetto da LMC ad alto rischio Sokal in fallimento dopo inatinib ad alte dosi 50
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study 50
Risk stratification and early cardiotoxicity identification: organizational advantages and clinical impact of intrahospital cardiotoxicity network 50
A multivariate analysis of Multiple Myeloma subtype plasma cells 50
JAK2 V617F-positive latent essential thrombocythemia and splanchnic vein thrombosis: the role of bone marrow biopsy for the diagnosis of myeloproliferative disease. 49
Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells 49
SIRT2 and SIRT3 expression correlates with redox imbalance and advanced clinical stage in patients with multiple myeloma 49
Increase in serum protein carbonyl groups is associated with more advanced stage of disease in multiple myeloma patients. 48
Decreased plasma levels of IL-33 could contribute to the altered function of Th2 Iymphocytes in patients with poIycythemia vera and essential thrombocythemia. 48
Possible role of Interleuki-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity 48
MicroRNA profiling in asthma: Potential biomarkers and therapeutic targets 48
FITC-labelled clone from phage display for direct detection of leukemia cells in blood 48
The adipose organ and multiple myeloma: Impact of adipokines on tumor growth and potential sites for therapeutic intervention 48
Cellule endoteliali progenitrici circolanti e osteonecrosi mascellare da bifosfonati. 47
Effetti di uno stress fisico sulla funzione pistrinica e su alcuni parametri emocoagulativi e della fibrinolisi 47
Curcumin Ameliorates the In Vitro Efficacy of Carfilzomib in Human Multiple Myeloma U266 Cells Targeting p53 and NF-κB Pathways. 47
Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies. 46
Serum levels of Interleukin-16 in a multiple myeloma patient with cutaneous involvement 46
Serum levels of 2',5 oligoadenylate synthetase during interferon therapy in patients with B-cell chronic lymphocytic leukemia 46
Increase of IL-17, IL-22 and IL-23 serum levels induced by immunoglobulin infusion for Parvovirus-B associated Pure Red Cell Aplasia in a renal transplant recipient. 46
Prognostic value of serum thymidine kinase and beta 2 microglobulin in subjects affected by multiple myeloma 46
Interleukin 22 is increased and correlated with CD38 expression in patients with B-chronic lymphocytic leukemia 46
Changes in serum interleukin-8 and sRAGE levels in multiple myeloma patients 46
A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma 46
Totale 6.120
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.009
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.009
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.523 177 76 13 72 35 248 209 145 27 243 258 20
2020/20211.766 211 38 300 91 150 174 36 170 133 243 120 100
2021/20221.629 16 118 24 73 54 22 99 64 55 223 220 661
2022/20234.570 409 389 214 408 311 464 53 229 1.855 27 146 65
2023/20241.076 99 195 70 83 97 246 26 70 11 26 16 137
2024/202545 45 0 0 0 0 0 0 0 0 0 0 0
Totale 11.833